We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMTI icon
13176
CALL
Rockwell Medical
RMTI
$28.2M
$16K ﹤0.01%
301
+153
+103% +$6.48K
XIN
13177
DELISTED
Xinyuan Real Estate
XIN
$16K ﹤0.01%
+1,446
New +$10.8K
CIRC
13178
Circle8 Group
CIRC
$65.1M
$16K ﹤0.01%
281
-660
-70% -$38.3K
BLNE
13179
Beeline Holdings
BLNE
$33.2M
$16K ﹤0.01%
81
-351
-81% -$79.9K
GHSI
13180
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$16K ﹤0.01%
1,339
+1,128
+535% +$22.9K
AIU
13181
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
$16K ﹤0.01%
2,028
-578
-22% -$9.46K
AIH
13182
DELISTED
Aesthetic Medical International Holdings
AIH
$16K ﹤0.01%
+10,100
New +$28.5K
ALLG.WS
13183
DELISTED
Allego N.V. Warrants
ALLG.WS
$16K ﹤0.01%
+15,060
New +$17.8K
NYMX
13184
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$16K ﹤0.01%
+12,700
New +$19.6K
APTO
13185
DELISTED
Aptose Biosciences, Inc.
APTO
$16K ﹤0.01%
27
-225
-89% -$124K
AGRX
13186
CALL
DELISTED
Agile Therapeutics
AGRX
$16K ﹤0.01%
38
-34
-47% -$21.7K
IVC
13187
DELISTED
Invacare Corporation
IVC
$16K ﹤0.01%
11,525
-11,461
-50% -$24.5K
CALA
13188
CALL
DELISTED
Calithera Biosciences, Inc
CALA
$16K ﹤0.01%
1,920
-3,305
-63% -$33.8K
WEI
13189
DELISTED
Weidai Ltd. American depositary shares, each representing five (5) Class A ordinary shares
WEI
$16K ﹤0.01%
14,655
+2,473
+20% +$5.02K
VISL
13190
PUT
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$16K ﹤0.01%
+765
New +$15.5K
ZNB
13191
Zeta Network Group
ZNB
$2.4M
0
CMCM
13192
CALL
Cheetah Mobile
CMCM
$96.5M
$15K ﹤0.01%
3,100
-8,080
-72% -$48.7K
FENG
13193
PUT
Phoenix New Media
FENG
$18M
$15K ﹤0.01%
+4,367
New +$18.9K
TLSA icon
13194
Tiziana Life Sciences
TLSA
$127M
$15K ﹤0.01%
+13,973
New +$12.4K
LMDXW
13195
DELISTED
LumiraDx Limited Warrant
LMDXW
$15K ﹤0.01%
18,570
-2,861
-13% -$3.68K
NYMX
13196
DELISTED
Nymox Pharmaceutical Corp
NYMX
$15K ﹤0.01%
+12,240
New +$18.9K
APTO
13197
PUT
DELISTED
Aptose Biosciences, Inc.
APTO
$15K ﹤0.01%
24
-137
-85% -$75.8K
QTT
13198
CALL
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$15K ﹤0.01%
+10,000
New +$20.3K
QTNT
13199
CALL
DELISTED
Quotient Limited Ordinary Shares
QTNT
$15K ﹤0.01%
315
-738
-70% -$44.1K
GNCA
13200
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
$15K ﹤0.01%
12,000
-47,100
-80% -$51.3K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.